Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma

NCT06079164 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Large B-cell Lymphoma

Interventions

DRUG: KITE-197
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Kite, A Gilead Company